Our findings concerning the ability of these methods to detect mutations in KRAS are similar to those of Whitehall et al. (2009), who compared Dideoxy sequencing, HRM, the TIB Molbiol kit (Berlin, Germany), and the TheraScreen DxS (Manchester, UK) kit using DNA isolated from frozen colorectal cancer tissues. The gene discussed is KRAS; the disease is colorectal cancer.